Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

BACKGROUND: Gonadotropin-releasing hormone agonists (GnRH) used in prostate cancer (PCa) are associated with atherogenic dyslipidaemia. It can be assumed that GnRH need to be used with greater caution in men with type 2 diabetes mellitus (T2DM). This study investigated association of GnRH with ather...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, E., Garmo, Hans, Hagström, Emil, Van Hemelrijck, Mieke, Adolfsson, Jan, Stattin, Pär, Zethelius, Björn, Crawley, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977763/
https://www.ncbi.nlm.nih.gov/pubmed/36522475
http://dx.doi.org/10.1038/s41416-022-02091-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977763/
https://www.ncbi.nlm.nih.gov/pubmed/36522475
http://dx.doi.org/10.1038/s41416-022-02091-z

Ejemplares similares